Literature DB >> 33614286

Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma.

Chen Yang1,2, Shufang Xie2,3, Yi Wu4, Guoqing Ru5, Xianglei He5, Hong-Yin Pan6, Shibing Wang2,7, Xiangmin Tong2,7.   

Abstract

BACKGROUND: The overall prognosis of hepatocellular carcinoma (HCC) is poor and novel prognostic biomarkers might better monitor the progression of HCC. Cell division cycle protein 45 (CDC45) plays a key role in DNA replication and considered to be involved in tumorigenesis. This study investigated CDC45 expression in tumour tissues and defined its prognostic value in HCC patients.
METHODS: We used immunohistochemistry (IHC) staining to examine the expression of CDC45 in tumour tissue specimens and compare them with adjacent normal tissue specimens using a constructed tissue microarray (TMA) and analyzed how clinical features are related to HCC prognosis. Functional enrichment analyses were used to describe significantly involved hallmark pathways of differentially expressed genes (DEGs, which were screened out according to the high or low expression of CDC45 in tumour tissues).
RESULTS: Our findings showed that the proteome expression of CDC45 was evidently downregulated in HCC tissues compared with matched normal tissues (P < 0.0001). Although we did not find any differences in terms of vascular invasion, metastasis, lymphatic infiltration, or Edmondson grade between patients with high and low CDC45 expression, low CDC45 expression was significantly correlated with microvascular invasion (P = 0.046). Multivariate analysis indicated that CDC45 expression (P = 0.035) was an independent prognostic factor for the overall survival (OS) rate of HCC patients. Patients with CDC45 expression was positively correlated with OS rates among HCC patients (P < 0.05). Functional annotations indicated that CDC45 is involved in the most significant pathways, including the cell cycle, DNA replication, chemical carcinogenesis and drug metabolism-cytochrome P450 pathways. DISCUSSION: Our findings showed that low proteomic level of CDC45 was associated with a poor prognosis in HCC patients, indicating that CDC45 might be a novel prognostic marker. ©2021 Yang et al.

Entities:  

Keywords:  Bioinformatics; Biomarker; Cell division cycle protein 45; Hepatocellular carcinoma

Year:  2021        PMID: 33614286      PMCID: PMC7883691          DOI: 10.7717/peerj.10824

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  24 in total

Review 1.  DNA replication and homologous recombination factors: acting together to maintain genome stability.

Authors:  Antoine Aze; Jin Chuan Zhou; Alessandro Costa; Vincenzo Costanzo
Journal:  Chromosoma       Date:  2013-04-16       Impact factor: 4.316

2.  Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.

Authors:  Ani Kardashian; Sander S Florman; Brandy Haydel; Richard M Ruiz; Goran B Klintmalm; David D Lee; C Burcin Taner; Federico Aucejo; Amit D Tevar; Abhinav Humar; Elizabeth C Verna; Karim J Halazun; William C Chapman; Neeta Vachharajani; Maarouf Hoteit; Matthew H Levine; Mindie H Nguyen; Marc L Melcher; Alan N Langnas; Carol A Carney; Constance Mobley; Mark Ghobrial; Beth Amundsen; James F Markmann; Debra L Sudan; Christopher M Jones; Jennifer Berumen; Alan W Hemming; Johnny C Hong; Joohyun Kim; Michael A Zimmerman; Trevor L Nydam; Abbas Rana; Michael L Kueht; Thomas M Fishbein; Daniela Markovic; Ronald W Busuttil; Vatche G Agopian
Journal:  Hepatology       Date:  2020-12       Impact factor: 17.425

3.  Cdc45 protein-single-stranded DNA interaction is important for stalling the helicase during replication stress.

Authors:  Irina Bruck; Daniel L Kaplan
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

Review 4.  Regulation of Cdc45 in the cell cycle and after DNA damage.

Authors:  Ronan Broderick; Heinz-Peter Nasheuer
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

5.  The human homolog of Saccharomyces cerevisiae CDC45.

Authors:  P Saha; K C Thome; R Yamaguchi; Z Hou; S Weremowicz; A Dutta
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

6.  NCBI GEO: archive for functional genomics data sets--update.

Authors:  Tanya Barrett; Stephen E Wilhite; Pierre Ledoux; Carlos Evangelista; Irene F Kim; Maxim Tomashevsky; Kimberly A Marshall; Katherine H Phillippy; Patti M Sherman; Michelle Holko; Andrey Yefanov; Hyeseung Lee; Naigong Zhang; Cynthia L Robertson; Nadezhda Serova; Sean Davis; Alexandra Soboleva
Journal:  Nucleic Acids Res       Date:  2012-11-27       Impact factor: 16.971

7.  Cdc45 is limiting for replication initiation in humans.

Authors:  Carsten Köhler; Dennis Koalick; Anja Fabricius; Ann Christin Parplys; Kerstin Borgmann; Helmut Pospiech; Frank Grosse
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

8.  Atypical role of sprouty in colorectal cancer: sprouty repression inhibits epithelial-mesenchymal transition.

Authors:  Q Zhang; T Wei; K Shim; K Wright; K Xu; H L Palka-Hamblin; A Jurkevich; S Khare
Journal:  Oncogene       Date:  2015-10-05       Impact factor: 9.867

9.  Potential Prognostic and Diagnostic Values of CDC6, CDC45, ORC6 and SNHG7 in Colorectal Cancer.

Authors:  Yang Hu; Liping Wang; Zhixing Li; Zirui Wan; Mingjie Shao; Shaobin Wu; Guo Wang
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

10.  Helicase Subunit Cdc45 Targets the Checkpoint Kinase Rad53 to Both Replication Initiation and Elongation Complexes after Fork Stalling.

Authors:  Geylani Can; Anastasia Christine Kauerhof; Dominik Macak; Philip Zegerman
Journal:  Mol Cell       Date:  2018-12-27       Impact factor: 17.970

View more
  2 in total

1.  Identification of Potential Biomarkers for Pan-Cancer Diagnosis and Prognosis Through the Integration of Large-Scale Transcriptomic Data.

Authors:  Lin Zhu; Yu Miao; Feng Xi; Pingping Jiang; Liang Xiao; Xin Jin; Mingyan Fang
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

2.  Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma.

Authors:  Lishi Shao; Lei Liang; Qixiang Fang; Jiaping Wang
Journal:  Heliyon       Date:  2022-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.